Benzinga (Mon, 25-Mar 10:32 AM ET)
Alvotech Announces Increase in Number of Own Shares
Globe Newswire (Fri, 22-Mar 4:15 PM ET)
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Globe Newswire (Wed, 20-Mar 4:15 PM ET)
Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
Globe Newswire (Tue, 5-Mar 4:00 PM ET)
Alvotech Appoints Interim Chief Quality Officer
Globe Newswire (Thu, 29-Feb 4:05 PM ET)
Globe Newswire (Mon, 26-Feb 4:25 AM ET)
Globe Newswire (Fri, 23-Feb 8:15 PM ET)
Business Wire (Fri, 23-Feb 8:15 PM ET)
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara (ustekinumab)
Globe Newswire (Thu, 15-Feb 6:30 AM ET)
Globe Newswire (Mon, 29-Jan 4:00 AM ET)
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
Alvotech - trades on the NASDAQ stock market under the symbol ALVO.
As of March 28, 2024, ALVO stock price declined to $12.22 with 87,762 million shares trading.
ALVO has a beta of 0.72, meaning it tends to be less sensitive to market movements. ALVO has a correlation of 0.03 to the broad based SPY ETF.
ALVO has a market cap of $3.42 billion. This is considered a Mid Cap stock.
The top ETF exchange traded funds that ALVO belongs to (by Net Assets): STXK, FPXE.
ALVO has underperformed the market in the last year with a price return of -9.5% while the SPY ETF gained +33.6%. ALVO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +8.3% and -20.6%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
ALVO support price is $12.21 and resistance is $13.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALVO stock will trade within this expected range on the day.